When do clinical trial consent disclosures render a patent invalid?

http://www.twobirds.com/en/patenthub/shared/articles/2019/australia/when-do-clinical-trial-consent-disclosures-render-a-patent-invalid

In the recent case of InterPharma Pty Ltd v Hospira Inc (No 5) [2019] FCA 960 the Australian Federal Court has given patentees guidance as to novelty preserving practice in the conduct of clinical trials.

24 July 2019

Patents: possible defence to infringement by equivalence

http://www.twobirds.com/en/patenthub/shared/articles/2019/global/patents-possible-defence-to-infringement-by-equivalence

The Intellectual Property Enterprise Court (IPEC) has held that a patent was invalid but also considered a possible defence to infringement by equivalence.

03 April 2019

Pemetrexed: Italian Court reversed the first instance decision ordering a PI on the basis of Eli Lilly's patent

http://www.twobirds.com/en/patenthub/shared/articles/2018/italy/italian-court-reversed-the-first-instance-decision-ordering-a-pi-on-the-basis-of-eli-lillys-patent

Diverging from the previous decision, the Court pointed out that the relevance of the file history to construe the scope of protection of a patent and then the infringement of equivalence has to be carefully and prudentially evaluated.

11 December 2018

Patents: SPC for combination product

http://www.twobirds.com/en/patenthub/shared/articles/2018/uk/patents-spc-for-combination-product

The Patents Court has held that a Supplementary Protection Certificate (SPC) for a combination product was invalid, following a ruling from the European Court of Justice (ECJ) on the meaning of Article 3 of the Supplementary Protection Certificate Regulation ...

06 November 2018

Patents: insufficiency

http://www.twobirds.com/en/patenthub/shared/articles/2018/uk/patents-insufficiency

The Court of Appeal has held that two patents for the production of human antibodies using transgenic mice were not invalid for insufficiency.

14 May 2018